|Reviewed by Dr Pat Clarkson, Robyn Wilkinson, Brenda Hughes, Lejla Brkic|
Reviewed By Dr Jon Skinner, October 1999
Clear colourless solution 3mg/ml in 0.9% sodium chloride in 2ml vials. For IV administration only.
Each dose is charted on the stat page of the drug chart in mg/dose.
Administered by doctor or NS-ANP with doctor in attendance.
Dilute immediately prior to use to 1mg / ml by adding to sodium chloride 0.9% using our usual dilution method.
Filter prior to administration through a 0.22 micron filter
Administer by direct IV injection over 1 to 2 seconds.
Follow instantaneously with a rapid flush of sodium chloride 0.9%
Compatible with sodium chloride 0.9%. Adenosine 1mg/mL compatible with glucose 5% 10
|1||Adenosine Drug evaluation monograph. 1974 - 1993 Micromedex Inc. Vol 78, Exp 11/30/93.|
|2||Sanofi Winthrop Pty Ltd. When seconds count, count on Adenocor (Product Information) 1995. Oxford Clinical Communications Australia Pty Ltd.|
|3||Beral CI. Higher adenosine dosage required for supraventricular tachycardia in infants treated with theophylline. Clin Pediatrics 1993: 167-168.|
|4||Paul T, Pfammatter JP. Adenosine. An effective and safe antiarrhythmic drug in pediatrics. Paed. Cardiology 1997: 18; 118-126.|
|5||Stockley I. Drug Interactions 4th ed. The Pharmaceutical Press; 1996: London|
|6||Hansten P, Horn J. Drug Interactions Analysis and Management. Applied Therapeutics Inc.; July 1998: Vancouver.|
|7||Crosson J, Etheridge SP, Milstein S, Hesslein PS, Dunnigan A. Therapeutic and diagnostic utility of Adenosine during tachycardia evaluation in children. Am J Cardiol 1994; 74:155-160|
|8||Sherwood M, Lau K, Sholler G. Adenosine in the management of supraventricular tachycardia in children J Paediatr Child Health 1998;34:53-56|
|9||Ralston M, Knilans T, Hannon D, Daniels S. Use of adenosine for diagnosis and treatment of tachyarrhythmias in pediatric patients J Pediatr 1994; 124: 139-143|
|10||Ketkar V, Kolling W, et al. Stability of undiluted and diluted adenosine at three temperatures in syringes and bags. Am J Health- Syst Pharm 1998; 55: 466-70|